KLRA
Kailera Therapeutics Inc.

32
Mkt Cap
$2.2B
Volume
8.11M
52W High
$27.50
52W Low
$16.00
Price
$26.00
KLRA Fundamentals
Prev Close
$16.00
Open
$26.00
50D MA
$21.00
Beta
0.00
Avg. Volume
0.00
EPS (Annual)
-$1.76
Rev/Employee
$0.00
Loading...
Loading...

About

Kailera Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of a broad, advanced, and differentiated portfolio of clinical-stage injectable and oral therapies for the treatment of obesity. Its product candidate includes Ribupatide. The company was founded on May 08, 2024 and is headquartered in Waltham, MA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
145

Frequently Asked Questions

What is Market Cap of Kailera Therapeutics Inc.?
What is the 52-week high for Kailera Therapeutics Inc.?
What is the 52-week low for Kailera Therapeutics Inc.?
What is Kailera Therapeutics Inc. stock price today?
What was Kailera Therapeutics Inc. stock price yesterday?
What is the 50-day moving average of Kailera Therapeutics Inc.?
How many employees does Kailera Therapeutics Inc. have?

Latest KLRA News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.